TXG
10x Genomics, Inc.
Stock
$93.50+4.74 (+5.34%)Close Oct 2, 2026
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $617M | +16.6% |
| Gross profit | $432M | +13.1% |
| Operating income | −$88M | — |
| Net income | −$75M | — |
| EPS | −$0.59 | — |
| Free cash flow | $121M | — |
10x Genomics, Inc.
$93.50+4.74 (+5.34%)Close Oct 2, 2026
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $617M | +16.6% |
| Gross profit | $432M | +13.1% |
| Operating income | −$88M | — |
| Net income | −$75M | — |
| EPS | −$0.59 | — |
| Free cash flow | $121M | — |